Accepted answer
The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.
Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.
Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.
Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.
Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.
One laboratory, one method, one submission. Otherwise it is not a comparison.